InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (72 ops.)
Browse the complete record of transactions filed by Ares Trading S.A., Board Member / Significant Shareholder. Insider active across 1 companies, notably Precigen, INC.. Aggregated, 72 reports have been recorded. Total volume traded: €41m. The latest transaction was filed on 12 October 2021 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations72 total
€259,64463,900 shares@ €4.06330.016% mcap1.3% of flow
Common Stock
SEC:0001104659-21-126314·
€259,64463,900 shares@ €4.06330.016% mcap0.6% of flow
Common Stock
SEC:0001104659-21-126314:0·
€192,10947,304 shares@ €4.06120.012% mcap0.9% of flow
Common Stock
SEC:0001104659-21-125461·
€192,10947,304 shares@ €4.06120.012% mcap0.5% of flow
Common Stock
SEC:0001104659-21-125461:0·
€201,90447,800 shares@ €4.22390.013% mcap1.0% of flow
Common Stock
SEC:0001104659-21-124738·
€201,90447,800 shares@ €4.22390.013% mcap0.5% of flow
Common Stock
SEC:0001104659-21-124738:0·
€41,9169,700 shares@ €4.32120.0027% mcap0.2% of flow
Common Stock
SEC:0001104659-21-123731·
€41,9169,700 shares@ €4.32120.0027% mcap0.1% of flow
Common Stock
SEC:0001104659-21-123731:0·
€441100 shares@ €4.40620.0000% mcap0.0% of flow
Common Stock
SEC:0001104659-21-122492·
€441100 shares@ €4.40620.0000% mcap0.0% of flow
Common Stock
SEC:0001104659-21-122492:0·
€24,3654,584 shares@ €5.31520.0015% mcap0.1% of flow
Common Stock
SEC:0001104659-21-115586·
€24,3654,584 shares@ €5.31520.0015% mcap0.1% of flow
Common Stock
SEC:0001104659-21-115586:0·
€12,6552,400 shares@ €5.27270.0008% mcap0.1% of flow
Common Stock
SEC:0001104659-21-114763·
€12,6552,400 shares@ €5.27270.0008% mcap0.0% of flow
Common Stock
SEC:0001104659-21-114763:0·
€157,03929,065 shares@ €5.4030.0100% mcap0.8% of flow
Common Stock
SEC:0001104659-21-113889·
€157,03929,065 shares@ €5.4030.0100% mcap0.4% of flow
Common Stock
SEC:0001104659-21-113889:0·
€1m254,932 shares@ €5.24440.085% mcap6.6% of flow
Common Stock
SEC:0001104659-21-113025·
€1m254,932 shares@ €5.24440.085% mcap3.3% of flow
Common Stock
SEC:0001104659-21-113025:0·
€151,77630,000 shares@ €5.05920.0096% mcap0.8% of flow
Common Stock
SEC:0001104659-21-112129·
€151,77630,000 shares@ €5.05920.0096% mcap0.4% of flow
Common Stock
SEC:0001104659-21-112129:0·
€562,654111,229 shares@ €5.05850.036% mcap2.8% of flow
Common Stock
SEC:0001104659-21-111143·
€562,654111,229 shares@ €5.05850.036% mcap1.4% of flow
Common Stock
SEC:0001104659-21-111143:0·
€166,70433,407 shares@ €4.99010.011% mcap0.8% of flow
Common Stock
SEC:0001104659-21-109874·
€166,70433,407 shares@ €4.99010.011% mcap0.4% of flow
Common Stock
SEC:0001104659-21-109874:0·
€274,67752,031 shares@ €5.27910.017% mcap1.4% of flow
Common Stock
SEC:0001104659-21-107083·
25 of 72 declarations
About Ares Trading S.A.
Ares Trading S.A. is best described, in the context of PRECIGEN, INC., as a significant shareholder and strategic counterpart rather than a day-to-day operating executive. Public filings and market data reviewed for Precigen identify Ares Trading S.A. as a substantial holder of the company’s equity, with the most recently located disclosure indicating ownership of roughly 8.3% of Precigen’s outstanding common stock. That level of ownership points to a meaningful governance and capital-markets presence, especially for a U.S.-listed biotechnology company, but it does not by itself establish an executive title such as Chief Executive Officer or Chief Financial Officer. The available sources do not provide a reliable individual biography, nor do they clearly link Ares Trading S.A. to a named operational leader at Precigen. As a result, the safest accurate description is that of a notable strategic investor with influence through ownership and corporate involvement, while avoiding unsupported claims about a personal career path, prior companies led, or specific management decisions.
